🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06707350
Starting soon Not applicable

Protective Effect of RIPC Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery (Panda VII)

NCT06707350 · tracked via the Priya Life Science China tracker
Sponsor
Nanjing Medical University
Phase
Not applicable
Started
2024-12-01
Last updated
2024-11-27

Condition(s) studied

Cardiopulmonary BypassCardiovascular DiseasesInflammatory Response During Cardiac Surgery

Investigational drug(s) / intervention(s)

Remote ischemic preconditioning (RIPC)sham condition (control group)

Remote ischemic preconditioning (RIPC): 8 cycles of 5-minute inflation and 5-minute deflation on 2 upper and lower limbs with a blood pressure cuff

sham condition (control group): 8 cycles of 5-minute inflation to a pressure of 20 mm Hg followed by 5-minute cuff deflation.

Study summary

Remote ischaemic pre-conditioning (RIPC) has been recognized as a low-cost, non-invasive intervention method by applying brief ischaemia and reperfusion on an arm or a leg. Previous studies have mainly focused on the organoprotective effects of RIPC in patients undergoing cardiac surgery. However, whether it has an organ-protecting effect is still highly debated. We aimed to determine whether intensive RIPC can prevent from negative inflammatory response and organ dysfunction as well as postoperative complications in patients undergoing cardiovascular surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * patients at high risk for organ dysfunctions who underwent elective cardiovascular surgery requiring cardiopulmonary bypass (CPB); * age of 18 -80 years old, regardless of gender; * subjects voluntarily participate in the trialand sign the informed consent; Exclusion Criteria: * 1\) Arm fracture, skin injury or infection; * 2\) There is limb nerve injury; * 3\) Limb placement PICC, arteriovenous fistula and other devices that affect armband placement; * 4\) There are basic vascular lesions and poor blood supply at the extremities; * 5\) Limb thrombosis.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu

More Nanjing Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06707350 on ClinicalTrials.gov ↗ ← All trials in China